Position in IBRX
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$2,652,666
+$601,020 QoQ
Shares Held
302,989
+13.3% QoQ
Ownership
0.029%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#62
of 403 holders
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 0%
Shared 97%
None 3%
Common Shares in IBRX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Invesco Ltd. holds $14,221,834,024 across 296 Biotechnology names. IBRX ranks #105 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
8,043,052 | $3,995,225,212 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
3,940,665 | $2,457,162,245 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
3,754,318 | $1,130,162,341 | |
| 4 | INCY |
Incyte Corp
|
4,080,461 | $462,561,050 | |
| 5 | ARGX |
Argenx SE
|
443,990 | $411,920,598 | |
| 6 | AXSM |
Axsome Therapeutics, Inc.
|
1,671,684 | $409,178,086 | |
| 7 | MRNA |
Moderna, Inc.
|
5,780,299 | $404,794,337 | |
| 8 | LGND |
Ligand Pharmaceuticals Inc
|
1,201,644 | $379,827,645 |
All Filings in IBRX
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,652,666 | 302,989 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $2,051,646 | 267,490 | Shares | Defined | 2026-05-12 | |
| 2025-12-31 | $362,013 | 182,836 | Shares | Defined | 2026-02-19 | |
| 2025-09-30 | $392,327 | 159,483 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $343,596 | 130,151 | Shares | Defined | 2025-08-13 | |
| 2025-03-31 | $331,513 | 110,138 | Shares | Defined | 2025-05-12 | |
| 2024-12-31 | $168,180 | 65,696 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $233,559 | 62,785 | Shares | Defined | 2024-11-12 | |
| 2024-06-30 | $385,613 | 61,015 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $6,804,550 | 1,267,142 | Shares | Defined | 2024-05-14 | |
| 2023-12-31 | $3,219,639 | 641,363 | Shares | Defined | 2024-02-13 | |
| 2023-09-30 | $76,848 | 45,473 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $124,213 | 44,681 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $76,859 | 42,231 | Shares | Defined | 2023-05-12 | |
| 2022-12-31 | $1,687,578 | 332,856 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $207,476 | 41,746 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $145,272 | 39,052 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $200,320 | 35,708 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $201,928 | 33,212 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $399,309 | 40,997 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $574,869 | 40,257 | Shares | Defined | 2021-08-17 | |
| 2021-03-31 | $254,540 | 10,722 | Shares | Defined | 2021-05-17 | |
| 2020-12-31 NK | — | 343,739 | Shares | Defined | 2021-02-16 | |
| 2020-06-30 NK | — | 449,003 | Shares | Defined | 2020-08-14 | |
| 2020-03-31 NK | — | 22,100 | Shares | Defined | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||